

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vitamin catabolic process (GO:0009111) | 6.23580050 |
| 2 | fat-soluble vitamin catabolic process (GO:0042363) | 6.23580050 |
| 3 | gonadal mesoderm development (GO:0007506) | 5.85818146 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.63975608 |
| 5 | cellular response to ATP (GO:0071318) | 5.55711697 |
| 6 | mature B cell differentiation involved in immune response (GO:0002313) | 5.46802984 |
| 7 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.44847722 |
| 8 | regulation of female gonad development (GO:2000194) | 5.20165670 |
| 9 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 5.11118429 |
| 10 | positive regulation of male gonad development (GO:2000020) | 4.97509137 |
| 11 | regulation of female receptivity (GO:0045924) | 4.90978205 |
| 12 | positive regulation of heat generation (GO:0031652) | 4.85403870 |
| 13 | skeletal muscle tissue regeneration (GO:0043403) | 4.85125043 |
| 14 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.63500652 |
| 15 | lymphangiogenesis (GO:0001946) | 4.48391391 |
| 16 | female mating behavior (GO:0060180) | 4.42140039 |
| 17 | regulation of vitamin metabolic process (GO:0030656) | 4.35423009 |
| 18 | regulation of fever generation (GO:0031620) | 4.26107203 |
| 19 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.17802153 |
| 20 | polarized epithelial cell differentiation (GO:0030859) | 4.11148136 |
| 21 | mature B cell differentiation (GO:0002335) | 4.08278218 |
| 22 | positive regulation of antigen processing and presentation (GO:0002579) | 4.05506754 |
| 23 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.93872086 |
| 24 | regulation of heat generation (GO:0031650) | 3.89740622 |
| 25 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.85747499 |
| 26 | regulation of male gonad development (GO:2000018) | 3.74035449 |
| 27 | response to caffeine (GO:0031000) | 3.74015555 |
| 28 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.69458004 |
| 29 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.60989433 |
| 30 | ventricular septum morphogenesis (GO:0060412) | 3.53640766 |
| 31 | synaptic transmission, dopaminergic (GO:0001963) | 3.50134765 |
| 32 | kidney morphogenesis (GO:0060993) | 3.47012523 |
| 33 | lipoxygenase pathway (GO:0019372) | 3.46316606 |
| 34 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.42535889 |
| 35 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.42522113 |
| 36 | regulation of chronic inflammatory response (GO:0002676) | 3.37511604 |
| 37 | negative regulation of oxidoreductase activity (GO:0051354) | 3.35431421 |
| 38 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.33171848 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.27260612 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.27260612 |
| 41 | tryptophan catabolic process (GO:0006569) | 3.27260612 |
| 42 | sulfation (GO:0051923) | 3.25805763 |
| 43 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.21008477 |
| 44 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.19777939 |
| 45 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.18994054 |
| 46 | coenzyme catabolic process (GO:0009109) | 3.14566256 |
| 47 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.14358230 |
| 48 | detection of light stimulus involved in visual perception (GO:0050908) | 3.14358230 |
| 49 | negative regulation of lipid storage (GO:0010888) | 3.13441301 |
| 50 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.12676193 |
| 51 | negative regulation of mast cell activation (GO:0033004) | 3.09122429 |
| 52 | protein targeting to lysosome (GO:0006622) | 3.07629800 |
| 53 | establishment of protein localization to vacuole (GO:0072666) | 3.07629800 |
| 54 | protein targeting to vacuole (GO:0006623) | 3.07629800 |
| 55 | negative regulation of glucose transport (GO:0010829) | 3.05709306 |
| 56 | regulation of antigen processing and presentation (GO:0002577) | 3.05335911 |
| 57 | activation of adenylate cyclase activity (GO:0007190) | 3.03216113 |
| 58 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.02211095 |
| 59 | negative regulation of blood pressure (GO:0045776) | 3.02036414 |
| 60 | venous blood vessel morphogenesis (GO:0048845) | 2.97389793 |
| 61 | cellular glucuronidation (GO:0052695) | 2.96430416 |
| 62 | kynurenine metabolic process (GO:0070189) | 2.96378741 |
| 63 | glycosphingolipid biosynthetic process (GO:0006688) | 2.90962626 |
| 64 | regulation of chemokine biosynthetic process (GO:0045073) | 2.90146650 |
| 65 | positive regulation of chemokine secretion (GO:0090197) | 2.87466556 |
| 66 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.86145818 |
| 67 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.84200231 |
| 68 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.82377533 |
| 69 | negative regulation of interleukin-12 production (GO:0032695) | 2.81047906 |
| 70 | neuronal action potential (GO:0019228) | 2.80233178 |
| 71 | glucuronate metabolic process (GO:0019585) | 2.78658631 |
| 72 | uronic acid metabolic process (GO:0006063) | 2.78658631 |
| 73 | protein localization to lysosome (GO:0061462) | 2.70314546 |
| 74 | protein localization to vacuole (GO:0072665) | 2.70314546 |
| 75 | regulation of macrophage chemotaxis (GO:0010758) | 2.69493660 |
| 76 | regulation of sensory perception of pain (GO:0051930) | 2.68338142 |
| 77 | regulation of sensory perception (GO:0051931) | 2.68338142 |
| 78 | lateral sprouting from an epithelium (GO:0060601) | 2.67247610 |
| 79 | response to magnesium ion (GO:0032026) | 2.65819822 |
| 80 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.65680815 |
| 81 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.64901893 |
| 82 | response to ATP (GO:0033198) | 2.64551556 |
| 83 | pantothenate metabolic process (GO:0015939) | 2.62609537 |
| 84 | alanine transport (GO:0032328) | 2.59958938 |
| 85 | basic amino acid transport (GO:0015802) | 2.59592304 |
| 86 | negative regulation of glucose import (GO:0046325) | 2.59153780 |
| 87 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.57889268 |
| 88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57422609 |
| 89 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.57416036 |
| 90 | positive regulation of adenylate cyclase activity (GO:0045762) | 2.56995596 |
| 91 | regulation of germinal center formation (GO:0002634) | 2.56289794 |
| 92 | neural tube formation (GO:0001841) | 2.55693610 |
| 93 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.54930459 |
| 94 | negative regulation of interleukin-1 production (GO:0032692) | 2.53658266 |
| 95 | membrane depolarization during action potential (GO:0086010) | 2.52698767 |
| 96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.51456961 |
| 97 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.49884106 |
| 98 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.49621931 |
| 99 | outflow tract septum morphogenesis (GO:0003148) | 2.49501476 |
| 100 | retinal ganglion cell axon guidance (GO:0031290) | 2.46628770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.94513738 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.24624547 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.17073056 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.14079682 |
| 5 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.89891355 |
| 6 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.59519208 |
| 7 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.37332793 |
| 8 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 2.37332793 |
| 9 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.33051143 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.24821822 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20930609 |
| 12 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18690113 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13935525 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.06421788 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06138490 |
| 16 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.05912862 |
| 17 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.00640599 |
| 18 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98149460 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95318919 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.94686224 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.92693849 |
| 22 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.91481513 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.90918445 |
| 24 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.85773223 |
| 25 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.83221874 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.82746907 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.80568937 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.77755134 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.73214232 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.73214232 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.67637443 |
| 32 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.67600452 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.67443278 |
| 34 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.63658568 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.60574096 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56576320 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55607280 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54855153 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54666374 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.54533664 |
| 41 | AR_25329375_ChIP-Seq_VCAP_Human | 1.52389807 |
| 42 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.49636877 |
| 43 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.47817227 |
| 44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46817148 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42915850 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41769155 |
| 47 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.41018509 |
| 48 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.41018509 |
| 49 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.41018509 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40735081 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.40639391 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38897050 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38510247 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35603925 |
| 55 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31889466 |
| 56 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.31271620 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.30074131 |
| 58 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25930233 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25930233 |
| 60 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24433841 |
| 61 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23723954 |
| 62 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22610047 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20647643 |
| 64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19082001 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16776521 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16262973 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.15918335 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15385638 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10970973 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10908798 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10861161 |
| 72 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10800274 |
| 73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09048381 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06583553 |
| 75 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05757519 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04310448 |
| 77 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01658653 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01190781 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01173064 |
| 80 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00676490 |
| 81 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.99250494 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97752768 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97752768 |
| 84 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97285439 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97264211 |
| 86 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.96652536 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96450093 |
| 88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96100351 |
| 89 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96080038 |
| 90 | NCOR_22424771_ChIP-Seq_293T_Human | 0.94749412 |
| 91 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94370271 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94126417 |
| 93 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94029359 |
| 94 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93615579 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92612789 |
| 96 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92225605 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91534445 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90109925 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89818502 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88732344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002653_abnormal_ependyma_morphology | 5.28843157 |
| 2 | MP0003646_muscle_fatigue | 4.68303003 |
| 3 | MP0002736_abnormal_nociception_after | 4.32665870 |
| 4 | MP0009840_abnormal_foam_cell | 3.50140418 |
| 5 | MP0003724_increased_susceptibility_to | 3.39314480 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 3.21725328 |
| 7 | MP0003303_peritoneal_inflammation | 3.09681038 |
| 8 | MP0005409_darkened_coat_color | 3.00277406 |
| 9 | MP0005360_urolithiasis | 2.71878236 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.68974365 |
| 11 | MP0001188_hyperpigmentation | 2.68095188 |
| 12 | MP0004510_myositis | 2.40904909 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.26961694 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 2.21863931 |
| 15 | MP0003195_calcinosis | 2.19050670 |
| 16 | MP0002127_abnormal_cardiovascular_syste | 2.18066354 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.14204558 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.12149358 |
| 19 | MP0004043_abnormal_pH_regulation | 2.11743304 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.03260793 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.02140133 |
| 22 | MP0005253_abnormal_eye_physiology | 1.95097338 |
| 23 | MP0009764_decreased_sensitivity_to | 1.91916141 |
| 24 | MP0005646_abnormal_pituitary_gland | 1.88313741 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.75795511 |
| 26 | MP0009785_altered_susceptibility_to | 1.75213862 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.74221570 |
| 28 | MP0008004_abnormal_stomach_pH | 1.72323782 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.70354392 |
| 30 | MP0009697_abnormal_copulation | 1.69529615 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.66592910 |
| 32 | MP0006276_abnormal_autonomic_nervous | 1.44294787 |
| 33 | MP0000230_abnormal_systemic_arterial | 1.40501824 |
| 34 | MP0003136_yellow_coat_color | 1.39295316 |
| 35 | MP0006082_CNS_inflammation | 1.38903322 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.35110560 |
| 37 | MP0004742_abnormal_vestibular_system | 1.34066710 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.33790615 |
| 39 | MP0004085_abnormal_heartbeat | 1.28972664 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.28363372 |
| 41 | MP0001970_abnormal_pain_threshold | 1.26285324 |
| 42 | MP0003879_abnormal_hair_cell | 1.23604171 |
| 43 | MP0009379_abnormal_foot_pigmentation | 1.23481694 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.19503696 |
| 45 | MP0002163_abnormal_gland_morphology | 1.17631898 |
| 46 | MP0003638_abnormal_response/metabolism_ | 1.15707349 |
| 47 | MP0000516_abnormal_urinary_system | 1.14794211 |
| 48 | MP0005367_renal/urinary_system_phenotyp | 1.14794211 |
| 49 | MP0001879_abnormal_lymphatic_vessel | 1.14057830 |
| 50 | MP0005197_abnormal_uvea_morphology | 1.13241208 |
| 51 | MP0003329_amyloid_beta_deposits | 1.09291666 |
| 52 | MP0002254_reproductive_system_inflammat | 1.08029081 |
| 53 | MP0000604_amyloidosis | 1.07392191 |
| 54 | MP0002295_abnormal_pulmonary_circulatio | 1.05193117 |
| 55 | MP0003436_decreased_susceptibility_to | 1.04726547 |
| 56 | MP0002419_abnormal_innate_immunity | 1.01880989 |
| 57 | MP0001984_abnormal_olfaction | 0.99122116 |
| 58 | MP0003075_altered_response_to | 0.99080533 |
| 59 | MP0005620_abnormal_muscle_contractility | 0.97790306 |
| 60 | MP0000767_abnormal_smooth_muscle | 0.97244041 |
| 61 | MP0009046_muscle_twitch | 0.97010762 |
| 62 | MP0002272_abnormal_nervous_system | 0.95451227 |
| 63 | MP0005595_abnormal_vascular_smooth | 0.92895049 |
| 64 | MP0004084_abnormal_cardiac_muscle | 0.91315811 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 0.87729536 |
| 66 | MP0003633_abnormal_nervous_system | 0.86760006 |
| 67 | MP0005000_abnormal_immune_tolerance | 0.86304719 |
| 68 | MP0000343_altered_response_to | 0.85798636 |
| 69 | MP0005410_abnormal_fertilization | 0.85351368 |
| 70 | MP0001663_abnormal_digestive_system | 0.84474139 |
| 71 | MP0002572_abnormal_emotion/affect_behav | 0.82408821 |
| 72 | MP0000749_muscle_degeneration | 0.82133264 |
| 73 | MP0004859_abnormal_synaptic_plasticity | 0.81969103 |
| 74 | MP0001440_abnormal_grooming_behavior | 0.79883675 |
| 75 | MP0005671_abnormal_response_to | 0.78800621 |
| 76 | MP0002139_abnormal_hepatobiliary_system | 0.78119543 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.77380226 |
| 78 | MP0003950_abnormal_plasma_membrane | 0.76847196 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 0.76220202 |
| 80 | MP0003718_maternal_effect | 0.75958856 |
| 81 | MP0002733_abnormal_thermal_nociception | 0.75606275 |
| 82 | MP0005164_abnormal_response_to | 0.74969668 |
| 83 | MP0009278_abnormal_bone_marrow | 0.72518590 |
| 84 | MP0002064_seizures | 0.71493917 |
| 85 | MP0009250_abnormal_appendicular_skeleto | 0.71314949 |
| 86 | MP0009745_abnormal_behavioral_response | 0.70954359 |
| 87 | MP0001919_abnormal_reproductive_system | 0.70232424 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.69544576 |
| 89 | MP0005025_abnormal_response_to | 0.68636367 |
| 90 | MP0001835_abnormal_antigen_presentation | 0.66942792 |
| 91 | MP0000534_abnormal_ureter_morphology | 0.66533821 |
| 92 | MP0001790_abnormal_immune_system | 0.66278969 |
| 93 | MP0005387_immune_system_phenotype | 0.66278969 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.64211363 |
| 95 | MP0003890_abnormal_embryonic-extraembry | 0.64046623 |
| 96 | MP0006292_abnormal_olfactory_placode | 0.62310189 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.61984303 |
| 98 | MP0002063_abnormal_learning/memory/cond | 0.61570223 |
| 99 | MP0005391_vision/eye_phenotype | 0.61293601 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.60688703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 6.86491019 |
| 2 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.18007538 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 6.18007538 |
| 4 | Decreased central vision (HP:0007663) | 5.21104783 |
| 5 | Keratoconjunctivitis sicca (HP:0001097) | 4.94443484 |
| 6 | Keratoconjunctivitis (HP:0001096) | 4.79261084 |
| 7 | Poor head control (HP:0002421) | 4.49336466 |
| 8 | Birth length less than 3rd percentile (HP:0003561) | 4.36756438 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 4.27681128 |
| 10 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.17849789 |
| 11 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.17849789 |
| 12 | Abnormality of abdominal situs (HP:0011620) | 4.05435834 |
| 13 | Abdominal situs inversus (HP:0003363) | 4.05435834 |
| 14 | Breast hypoplasia (HP:0003187) | 4.04078459 |
| 15 | Abnormal ciliary motility (HP:0012262) | 3.88758221 |
| 16 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.68043214 |
| 17 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.57610352 |
| 18 | Stomatitis (HP:0010280) | 3.38048128 |
| 19 | Attenuation of retinal blood vessels (HP:0007843) | 3.34687583 |
| 20 | Dysautonomia (HP:0002459) | 3.28919478 |
| 21 | Failure to thrive in infancy (HP:0001531) | 3.25708203 |
| 22 | Abnormality of cochlea (HP:0000375) | 3.18566097 |
| 23 | Constricted visual fields (HP:0001133) | 3.14715171 |
| 24 | Clumsiness (HP:0002312) | 3.05955063 |
| 25 | Morphological abnormality of the inner ear (HP:0011390) | 3.05100285 |
| 26 | Optic neuritis (HP:0100653) | 3.05097198 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 3.05097198 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 2.98410402 |
| 29 | Cone-rod dystrophy (HP:0000548) | 2.95087248 |
| 30 | High anterior hairline (HP:0009890) | 2.94594853 |
| 31 | Depressed nasal tip (HP:0000437) | 2.89172359 |
| 32 | Increased corneal curvature (HP:0100692) | 2.87061793 |
| 33 | Keratoconus (HP:0000563) | 2.87061793 |
| 34 | Tinnitus (HP:0000360) | 2.82413238 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.78444179 |
| 36 | Distal arthrogryposis (HP:0005684) | 2.69539259 |
| 37 | Orchitis (HP:0100796) | 2.68139851 |
| 38 | Preauricular pit (HP:0004467) | 2.67579191 |
| 39 | Periauricular skin pits (HP:0100277) | 2.67579191 |
| 40 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.62783298 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.59642891 |
| 42 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.55358993 |
| 43 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.40088789 |
| 44 | Absent phalangeal crease (HP:0006109) | 2.38802276 |
| 45 | Hyperventilation (HP:0002883) | 2.38304087 |
| 46 | Vertigo (HP:0002321) | 2.30123198 |
| 47 | Keratitis (HP:0000491) | 2.28528019 |
| 48 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.28434565 |
| 49 | Spastic tetraparesis (HP:0001285) | 2.27970146 |
| 50 | Abnormality of the renal collecting system (HP:0004742) | 2.27079538 |
| 51 | Sclerocornea (HP:0000647) | 2.24367855 |
| 52 | Myositis (HP:0100614) | 2.19217534 |
| 53 | Alopecia of scalp (HP:0002293) | 2.19112270 |
| 54 | Rimmed vacuoles (HP:0003805) | 2.18433903 |
| 55 | Fair hair (HP:0002286) | 2.16678527 |
| 56 | Ulnar deviation of the wrist (HP:0003049) | 2.13855506 |
| 57 | Opisthotonus (HP:0002179) | 2.12760591 |
| 58 | Absent eyelashes (HP:0000561) | 2.10114380 |
| 59 | Myokymia (HP:0002411) | 2.03546656 |
| 60 | Follicular hyperkeratosis (HP:0007502) | 2.03310152 |
| 61 | Pendular nystagmus (HP:0012043) | 1.96952189 |
| 62 | Arterial thrombosis (HP:0004420) | 1.95260806 |
| 63 | Axonal loss (HP:0003447) | 1.95203054 |
| 64 | Choroideremia (HP:0001139) | 1.93000213 |
| 65 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.92644309 |
| 66 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.90687661 |
| 67 | Calcaneovalgus deformity (HP:0001848) | 1.89975747 |
| 68 | 2-3 toe syndactyly (HP:0004691) | 1.89488221 |
| 69 | Broad-based gait (HP:0002136) | 1.87329795 |
| 70 | Nonimmune hydrops fetalis (HP:0001790) | 1.86822046 |
| 71 | Protruding tongue (HP:0010808) | 1.85468742 |
| 72 | Microretrognathia (HP:0000308) | 1.82589112 |
| 73 | Patellar aplasia (HP:0006443) | 1.81549460 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79299475 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79299475 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79299475 |
| 77 | Photophobia (HP:0000613) | 1.79247539 |
| 78 | Absent hair (HP:0002298) | 1.77705827 |
| 79 | Abnormality of the costochondral junction (HP:0000919) | 1.76155238 |
| 80 | Abnormal finger flexion creases (HP:0006143) | 1.75725093 |
| 81 | Lymphangioma (HP:0100764) | 1.73086609 |
| 82 | Right ventricular cardiomyopathy (HP:0011663) | 1.71683197 |
| 83 | Abnormality of the calf musculature (HP:0001430) | 1.66724872 |
| 84 | Flat occiput (HP:0005469) | 1.65975826 |
| 85 | Stomach cancer (HP:0012126) | 1.65947478 |
| 86 | Limb-girdle muscle atrophy (HP:0003797) | 1.64761257 |
| 87 | Skin pits (HP:0100276) | 1.64405624 |
| 88 | Absent eyebrow (HP:0002223) | 1.63816315 |
| 89 | Abnormality of the pleura (HP:0002103) | 1.62113602 |
| 90 | Nasolacrimal duct obstruction (HP:0000579) | 1.62073786 |
| 91 | Mesangial abnormality (HP:0001966) | 1.61775010 |
| 92 | Inability to walk (HP:0002540) | 1.61456769 |
| 93 | Deformed tarsal bones (HP:0008119) | 1.59476035 |
| 94 | Disproportionate tall stature (HP:0001519) | 1.55806515 |
| 95 | Hypoplasia of the maxilla (HP:0000327) | 1.54952712 |
| 96 | Increased number of teeth (HP:0011069) | 1.54632716 |
| 97 | Gangrene (HP:0100758) | 1.53110230 |
| 98 | Eosinophilia (HP:0001880) | 1.52496865 |
| 99 | Inappropriate behavior (HP:0000719) | 1.51338230 |
| 100 | Pancreatic cysts (HP:0001737) | 1.51273688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 5.93263421 |
| 2 | BMPR1B | 3.24027100 |
| 3 | TGFBR1 | 3.12981299 |
| 4 | IRAK3 | 2.92604861 |
| 5 | PINK1 | 2.91937023 |
| 6 | OBSCN | 2.80533877 |
| 7 | CASK | 2.74205560 |
| 8 | TAOK3 | 2.56557469 |
| 9 | ACVR1B | 2.55689500 |
| 10 | ZAK | 2.30282481 |
| 11 | NME1 | 2.09567321 |
| 12 | DAPK2 | 2.04241404 |
| 13 | GRK7 | 2.02043755 |
| 14 | ADRBK2 | 2.00441160 |
| 15 | MAP2K2 | 1.90359630 |
| 16 | MKNK2 | 1.76340547 |
| 17 | SIK2 | 1.66329510 |
| 18 | FRK | 1.65223262 |
| 19 | NTRK2 | 1.62892188 |
| 20 | IKBKB | 1.61323641 |
| 21 | LATS2 | 1.61117729 |
| 22 | TXK | 1.60340511 |
| 23 | MAPK13 | 1.42739419 |
| 24 | NME2 | 1.41862306 |
| 25 | CDK4 | 1.41269681 |
| 26 | PNCK | 1.40640451 |
| 27 | SGK2 | 1.29015664 |
| 28 | MATK | 1.28289273 |
| 29 | INSRR | 1.28096478 |
| 30 | IKBKE | 1.26725216 |
| 31 | BLK | 1.26465308 |
| 32 | DDR2 | 1.20221268 |
| 33 | SGK494 | 1.19829523 |
| 34 | SGK223 | 1.19829523 |
| 35 | MAP2K1 | 1.19127344 |
| 36 | MAPK15 | 1.16978380 |
| 37 | NUAK1 | 1.11547677 |
| 38 | CAMK2A | 1.09248796 |
| 39 | PKN1 | 0.96912646 |
| 40 | ABL2 | 0.95687752 |
| 41 | MARK3 | 0.89303753 |
| 42 | MAP3K14 | 0.88969303 |
| 43 | NEK9 | 0.88937686 |
| 44 | PAK6 | 0.85187546 |
| 45 | MARK1 | 0.84195390 |
| 46 | MELK | 0.83919640 |
| 47 | CAMKK2 | 0.79881134 |
| 48 | CAMKK1 | 0.77543995 |
| 49 | IRAK4 | 0.76827938 |
| 50 | CSNK1G1 | 0.75677239 |
| 51 | TAOK2 | 0.72814259 |
| 52 | MKNK1 | 0.72414230 |
| 53 | CDK3 | 0.70968752 |
| 54 | CHEK2 | 0.70473461 |
| 55 | PRKACG | 0.69684028 |
| 56 | TBK1 | 0.69303488 |
| 57 | CSNK1G2 | 0.68383567 |
| 58 | MAP2K6 | 0.67073067 |
| 59 | CAMK4 | 0.66885740 |
| 60 | IRAK2 | 0.66844265 |
| 61 | CAMK1 | 0.65521215 |
| 62 | PRKCZ | 0.64750055 |
| 63 | SGK3 | 0.63285152 |
| 64 | TSSK6 | 0.62855070 |
| 65 | FGR | 0.62097942 |
| 66 | CSNK1G3 | 0.62050254 |
| 67 | CHUK | 0.61980368 |
| 68 | BMPR2 | 0.61869342 |
| 69 | CDC42BPA | 0.58943868 |
| 70 | MAPK4 | 0.52907829 |
| 71 | STK38 | 0.52769198 |
| 72 | MOS | 0.52127390 |
| 73 | PHKG2 | 0.51273143 |
| 74 | PHKG1 | 0.51273143 |
| 75 | MAP2K7 | 0.51191748 |
| 76 | SYK | 0.50579504 |
| 77 | CSNK1A1L | 0.49926349 |
| 78 | PRKCG | 0.49335224 |
| 79 | TLK1 | 0.48237566 |
| 80 | STK38L | 0.47409638 |
| 81 | LYN | 0.47224533 |
| 82 | DYRK2 | 0.46119496 |
| 83 | MAP3K4 | 0.43554491 |
| 84 | ADRBK1 | 0.42218403 |
| 85 | PRKACA | 0.41696878 |
| 86 | CSNK1A1 | 0.41016700 |
| 87 | MAPK12 | 0.39505652 |
| 88 | MUSK | 0.38661255 |
| 89 | PIM1 | 0.38375948 |
| 90 | CSK | 0.37753686 |
| 91 | TIE1 | 0.36731477 |
| 92 | RPS6KA6 | 0.35667786 |
| 93 | AURKA | 0.34669706 |
| 94 | DYRK3 | 0.33974192 |
| 95 | NEK2 | 0.32354862 |
| 96 | RIPK1 | 0.27155244 |
| 97 | PRKG2 | 0.26474437 |
| 98 | RPS6KB1 | 0.26169859 |
| 99 | CAMK2B | 0.25735533 |
| 100 | PTK2B | 0.25452668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.51550126 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40972787 |
| 3 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.30592902 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.28596713 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.18036789 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.16642422 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.10849718 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.08152394 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97080318 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.94861731 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 1.90630696 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.87783396 |
| 13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87549794 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.87226640 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85260186 |
| 16 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.85071288 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.78204441 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74163834 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71838951 |
| 20 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.68339757 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.66969626 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65391494 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63085254 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.61314162 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.60991617 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.58121493 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.57376542 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52561712 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.52553407 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49401001 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48208735 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46234610 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.45237582 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43229428 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38859150 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35681098 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34873902 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.31052346 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29132855 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25663508 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21934107 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21342634 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13974938 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.11736845 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09855382 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.08556857 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08385806 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 1.06021527 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.03916312 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02100014 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01379743 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00553128 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96769394 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.93904732 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.91805083 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91488269 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.91346782 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88283285 |
| 59 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.82501746 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.81722095 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80750645 |
| 62 | Taste transduction_Homo sapiens_hsa04742 | 0.75790704 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73562927 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71987359 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70988619 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.70463678 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66872914 |
| 68 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63669990 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62760502 |
| 70 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62667801 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.60981556 |
| 72 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60083208 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57900733 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.57542544 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56751790 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56522180 |
| 77 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56346685 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54774649 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53397206 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52707540 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52634615 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50969722 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50538047 |
| 84 | Morphine addiction_Homo sapiens_hsa05032 | 0.49997514 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48501756 |
| 86 | Insulin secretion_Homo sapiens_hsa04911 | 0.47488959 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46655534 |
| 88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45684973 |
| 89 | Salivary secretion_Homo sapiens_hsa04970 | 0.45383576 |
| 90 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44011646 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.43086025 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43055930 |
| 93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42491894 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39271156 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39077064 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38881773 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38796938 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37263286 |
| 99 | Long-term depression_Homo sapiens_hsa04730 | 0.35936731 |
| 100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34803407 |

